Intel shareholder sues to void “extortionary” Trump‑era deal giving the US government a 10% stake in Intel for virtually no payment, alleging the board capitulated to illegal pressure and conflicts of interest

Intel shareholder sues to void “extortionary” Trump‑era deal giving the US government a 10% stake in Intel for virtually no payment, alleging the board capitulated to illegal pressure and conflicts of interest
news.bloomberglaw
Revision history

4 recorded changes

Want your article here?

Promote with Leviathan News

A derivative lawsuit filed in Delaware Chancery Court challenges Intel’s 2025 agreement to grant the U.S. government roughly a 10% equity stake on terms the plaintiff calls “extortionary,” alleging Intel’s board succumbed to unlawful political pressure from the Trump administration and failed its fiduciary duties to shareholders. According to reporting on the suit, the shareholder claims Intel effectively transferred a significant ownership position to the government for little or no net consideration, in order to avoid regulatory or public attacks, and seeks to have the deal voided and directors held liable. The challenged transaction is Intel’s August 2025 deal under which the U.S. government agreed to acquire about 9.9% of Intel via a primary share issuance of 433.3 million shares at $20.47 per share, funded by $8.9 billion in federal support that largely repurposed previously awarded but unpaid CHIPS Act and Secure Enclave grants. The arrangement also granted the government a five‑year warrant to acquire an additional 5% stake if Intel’s control of its foundry business dropped below 51%, while eliminating existing clawback and profit‑sharing terms on earlier CHIPS subsidies. Intel and the administration framed the deal as a way to cement domestic semiconductor manufacturing and align taxpayer upside with Intel’s long‑term success, with the government agreeing to be a passive shareholder without board seats and to generally vote with Intel’s board. The lawsuit, however, characterizes the structure as a backdoor equity transfer at shareholders’ expense, arguing that re‑labeling previously promised grants as “payment” for stock left Intel with little new value in exchange for substantial dilution, and that the board approved this under improper pressure from federal officials. The case highlights broader tensions around industrial policy and the CHIPS Act—specifically whether large, equity‑linked support packages for strategically important chipmakers cross into coercive state influence or conflict with directors’ duty to protect minority shareholders. If the court were to unwind or reprice the transaction, it could affect future government–corporate deals in critical infrastructure and tech, as well as Intel’s capital structure and U.S. industrial strategy alignment.

AI-generated background, compiled from web sources — not editorial content.

More coverage

Explore the topic

More on Trump

Comments